Tornado Platform - RNA Aptamers
Alzheimer's Disease, Parkinson's Disease, ALS (Lou Gehrig's Disease), Non-alcoholic steatohepatitis (NASH)
Pre-clinicalResearch & Development
Key Facts
Indication
Alzheimer's Disease, Parkinson's Disease, ALS (Lou Gehrig's Disease), Non-alcoholic steatohepatitis (NASH)
Phase
Pre-clinical
Status
Research & Development
Company
About Chimerna Therapeutics
Chimerna Therapeutics is a private biotech focused on unlocking the therapeutic potential of RNA through its innovative Tornado circularization platform. This technology allows cells to produce stable, circular RNAs that resist degradation, enabling the development of RNA aptamers, sponges, and other modalities for intracellular targets. The company is advancing its own pipeline in areas like Alzheimer's and NASH while also developing platform technologies to accelerate external drug discovery efforts, particularly in microRNA biology and recombinant protein production.
View full company profile